Expert Says Silver Stock Is in a Favorable Buy Spot
Contributed Opinion
Silver Producer Posts Strong Q1/24
Research Report
The Summer Stock Playlist
Contributed Opinion
Co. Poised for Growth in Silver-Rich Regions, Experts Say
Now With New Funding, Co. Can Restart Mine in Mexico
Research Report
Data Communications Co. Maintains Momentum in Q1
Pharma Co. Secures $650M Strategic Financing
Research Report
New Integrated Digital Platform Aims To Revolutionize Ticketing Industry
Fobi AI Inc. has introduced a new integrated event registration and digital ticketing platform, designed to change event registration. Read on to learn how it will effect the future of the industry.Jr.'s Maiden Drilling Confirms Uranium Mineralization
North Shore Uranium Ltd. announces results from maiden drilling at its Falcon uranium project in Saskatchewan's Athabasca Basin. Find out why one analyst thinks the news could be a big catalyst the stock.Joint Venture Partner Paid $17.5 Million in Cash in Q1/24
Research Report
If these cash distributions continue, as expected, the company may consider paying a dividend by year-end 2024, noted Roth MKM. Expert Says You May Want To Invest in This Startup
Contributed Opinion
Zefiro has an approved method to monetize methane reduction or abatement in North America that could generate high-margin cash flows for investors. Zefiro just had its first batch of methane abatement credits approved by the American Carbon Registry (ACR), one of the three leading registries worldwide. Ron Struthers of Struthers Resource Stock Report believes the opportunity is huge, with a $25 billion market in Pennsylvania alone, and that Zefiro has a first-mover advantage. Cash From Tier 1 Asset Flows to Silver Producer
As MAG Silver Corp. emerges as a producer with its Tier 1 Juanicipio mine in Mexico and output is beating estimates. Find out why at least one analyst thinks more of the fruits from the joint venture could land in investors' pockets.Clean Tech Co. Sees Positive Operating Cash Flow, Record Revenues
BioLargo Inc. announced record quarterly revenues of US$4.76 million for the three months ending March 31, a 28% increase over the first quarter of 2023. Find out why one analyst sees a bull market coming for the company.Pharma Stock Focuses on Successful Ensifentrine Launch
Research Report
Verona Pharma Plc. is well positioned to launch its ensifentrine into the substantial market of nearly 9 million COPD patients, according to a BTIG Research note. 
Streetwise Key Charts
